GSK and Fleming Initiative scientists unite to target AMR with advanced AI
Imperial wins Outstanding Entrepreneurial University at THE Awards
Imperial celebrates impact of supporters who gave £77.5 million in 2024-25
A partnership at Imperial has designed, synthesised, and characterised an entirely new fluorescent probe for HO-1
Find out more
A molecular protective mechanism for the clearance of haematomas
The future of profiling pulmonary hypertension?
COVID-19, cardiovascular SARS-CoV-2 receptors, the influence of age and susceptibility of endothelial cells to infection
How they affect endothelial activation and endothelial-platelet crosstalk
Metformin directly suppresses atherosclerosis and not by glucose reduction
A novel therapeutic strategy for pulmonary arterial hypertension
Investigating the impact of integrated non-invasive imaging
